Search

for
Search:

GlossaryJAK3 Inhibitor

blocks an enzyme involved in immune response and inflammation

A JAK3 Inhibitor, also known as a Janus Kinase 3 Inhibitor, is a type of medication that blocks the activity of the JAK3 enzyme. This enzyme is involved in the signaling pathways that regulate immune responses and inflammation. By inhibiting JAK3, these drugs can help treat autoimmune diseases and conditions like alopecia areata, where the immune system mistakenly attacks hair follicles.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 365 results

research Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda Minima

15 citations , June 2020 in “Processes”

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

research Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the Allegro Phase 2b/3 Study

September 2023 in “Dermatology and therapy”

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

research Effectiveness of OR-101, a Next Generation Highly Selective JAK3 Inhibitor, in a Humanized Murine Model of Alopecia Areata

November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology”

OR-101 shows promise for treating alopecia areata by improving hair growth.

research Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real-World Experience

February 2026 in “International Journal of Dermatology”

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

research Discovery Of A Novel And Highly Selective JAK3 Inhibitor As A Potent Hair Growth Promoter

April 2024 in “Journal of translational medicine”

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

View more "jak3 inhibitor" in research →

Community Join

0 / 0 results

— no results